Literature DB >> 6141993

Differentiated thyroid carcinoma, intermediate type: a new tumor entity with features of follicular and parafollicular cell carcinoma.

O Ljungberg, L Bondeson, A G Bondeson.   

Abstract

A group of differentiated thyroid carcinomas with morphologic and immunohistochemical traits of both follicular and medullary carcinoma is described. This group consists of tumors characterized by a solid and/or cribriform histologic pattern with a more or less pronounced admixture of follicular structures, immunohistochemical evidence for the production of thyroglobulin and one or more of the three neurohormonal peptides neurotensin, somatostatin, and calcitonin, and absence of amyloid. These tumors were selected from thyroid carcinomas that had been diagnosed, according to current histopathologic criteria, as differentiated follicular carcinomas. A series of pure follicular carcinomas, devoid of solid or cribriform structures, was found to contain thyroglobulin immunoreactive tumor cells only, whereas a series of classic medullary carcinoma with amyloid stroma revealed specific staining for all three neurohormonal peptides but not for thyroglobulin. The results suggest that differentiated thyroid carcinoma can be regarded as a continuous spectrum of tumor types, with pure follicular carcinomas and classic medullary carcinoma representing the two extremes and the tumors with biphasic features representing a broad intermediate group. The authors suggest that this group be designated "differentiated thyroid carcinoma, intermediate type."

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6141993     DOI: 10.1016/s0046-8177(84)80183-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  19 in total

1.  Mixed medullary and follicular carcinoma of the thyroid. On the search for its histogenesis.

Authors:  X Matias-Guiu
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 2.  How to define follicular thyroid carcinoma?

Authors:  Kurt Werner Schmid; Nadir Rashad Farid
Journal:  Virchows Arch       Date:  2006-02-28       Impact factor: 4.064

Review 3.  An evidence-based review of poorly differentiated thyroid cancer.

Authors:  Enoch M Sanders; Virginia A LiVolsi; James Brierley; Jennifer Shin; Gregory W Randolph
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 4.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

5.  Intermediate thyroid carcinoma in humans and ultimobranchial tumors in bulls: A comparative morphological and immunohistochemical study.

Authors:  Otto Ljungberg; Per Olle Nilson
Journal:  Endocr Pathol       Date:  1991-03       Impact factor: 3.943

6.  Merged histological types of malignant thyroid tumor: experience and controversy.

Authors:  Liang Huang; Yan Zhang
Journal:  Med Oncol       Date:  2011-01-04       Impact factor: 3.064

7.  Neuroendocrine marker expression in thyroid epithelial tumors.

Authors:  F Satoh; S Umemura; M Yasuda; R Y Osamura
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

8.  Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours.

Authors:  Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

9.  Coexistence of papillary and medullary carcinoma of the thyroid gland-mixed or collision tumour? Clinicopathological analysis of three cases.

Authors:  S F Lax; A Beham; D Kronberger-Schönecker; W Langsteger; H Denk
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 10.  Poorly differentiated thyroid carcinoma: diagnostic features and controversial issues.

Authors:  Marco Volante; Ida Rapa; Mauro Papotti
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.